TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 6 | -0 | -4 | -6 | -2 | -8 | -6 | -4 |
| S | %wins | 50 | 83 | 83 | 50 | 67 | 40 | 62 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/3/15 18:21 | 9/2/15 | RLYP | Relypsa Inc | Health | Drug | Pharmaceutical Preparations | Ball Kristine M | CA | O | CFO,SVP | S | -15 | 22.96 | 21 | -1 | -4 | 15 | D | -1 | -43 | -34 | -33 | 0 | 4 | -3 | 4 | 13 | -15 | 7 | -36 | |||
8/19/15 19:40 | 8/17/15 | RLYP | Relypsa Inc | Health | Drug | Pharmaceutical Preparations | Ball Kristine M | CA | O | CFO,SVP | S | -18 | 24.78 | 19 | -1 | -5 | 15 | D | -9 | -30 | -28 | -19 | -28 | -18 | 3 | -3 | -5 | -2 | -25 | -23 | 30 | ||
3/5/15 20:24 | 3/3/15 | RLYP | Relypsa Inc | Health | Drug | Pharmaceutical Preparations | Ball Kristine M | CA | O | CFO,SVP | S.dm | -143 | 40.68 | 16 | -4 | -32 | 8 | D | -1 | 61 | 60 | 13 | 23 | 2 | 3 | -4 | -4 | -18 | -16 | -48 | -70 | ||
1/23/15 21:44 | 1/21/15 | RLYP | Relypsa Inc | Health | Drug | Pharmaceutical Preparations | Ball Kristine M | CA | O | CFO,SVP | S.d | -108 | 36.00 | 16 | -3 | -29 | 8 | D | 6 | 47 | 96 | 18 | 20 | 10 | 10 | 1 | -3 | 6 | -4 | -4 | -47 | ||
11/12/03 19:15 | 11/12/03 | EXEL | Exelixis Inc | DE | Health | Biolab | Commercial Physical & Biologi | Ball Kristine M | CA | O | Controll | S | -33 | 7.01 | 2 | -5 | -49 | 5 | D | -47 | 16 | -13 | 3 | -8 | -4 | -6 | -6 | 1 | -12 | -3 | 14 | 31 | 29 |
11/12/03 14:21 | 11/11/03 | EXEL | Exelixis Inc | DE | Health | Biolab | Commercial Physical & Biologi | Ball Kristine M | CA | O | Controll | S | -60 | 6.92 | 2 | -9 | -48 | 10 | D | -47 | 16 | -13 | 3 | -8 | -4 | -6 | -6 | 0 | -12 | -4 | 13 | 31 | 29 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |